In the latest trading session, 66.96 million Revelation Biosciences Inc (NASDAQ:REVB) shares changed hands as the company’s beta touched 0.21. With the company’s most recent per share price at $2.36 changing hands around $1.32 or 127.27% at last look, the market valuation stands at $3.87M. REVB’s current price is a discount, trading about -1094.92% off its 52-week high of $28.20. The share price had its 52-week low at $0.81, which suggests the last value was 65.68% up since then. When we look at Revelation Biosciences Inc’s average trading volume, we note the 10-day average is 0.16 million shares, with the 3-month average coming to 664.17K.
Analysts gave the Revelation Biosciences Inc (REVB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended REVB as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Revelation Biosciences Inc’s EPS for the current quarter is expected to be -3.16.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Revelation Biosciences Inc (NASDAQ:REVB) trade information
Instantly REVB is in green as seen in intraday trades today. With action 161.38%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -84.29%, with the 5-day performance at 161.38% in the green. However, in the 30-day time frame, Revelation Biosciences Inc (NASDAQ:REVB) is 46.58% up. Looking at the short shares, we see there were 42054.0 shares sold at short interest cover period of 0.39 days.
Revelation Biosciences Inc (REVB) estimates and forecasts
Data shows that the Revelation Biosciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -25.08% over the past 6 months, a 66.29% in annual growth rate that is considerably higher than the industry average of 18.50%.
The 2024 estimates are for Revelation Biosciences Inc earnings to decrease by -2250.94%.
REVB Dividends
Revelation Biosciences Inc is expected to release its next quarterly earnings report in September.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.32% of Revelation Biosciences Inc shares while 3.12% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 3.13%.
Among Mutual Funds, the top two as of Jun 30, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 8.3 shares estimated at $19764.0 under it, the former controlled 0.51% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.01% of the shares, roughly 201.0 shares worth around $478.0.
